Recent research has highlighted the role of USP2, a deubiquitinase, in regulating inflammation by stabilizing SIX transcription factors. These fact...
Anixa Biosciences has announced the treatment of the second patient in the fourth cohort of its Phase 1 clinical trial for a novel CAR-T therapy ta...
Anixa Biosciences has treated the second patient in the fourth cohort of its Phase 1 clinical trial for ovarian cancer CAR-T therapy. The trial, co...
Researchers at the University of Delaware, led by Associate Professor William Chain, have developed a method to synthesize a molecule found in guav...
Recent research has highlighted the role of phagocytosis checkpoints in radiotherapy, focusing on the CD47/SIRPα axis and other related mechanisms....
The Lung Cancer Research Foundation (LCRF) has expanded its Scientific Advisory Board (SAB) by adding five new members, enhancing its capacity to g...
Bayer has unveiled new clinical trial data at the ASCO 2025 conference, showcasing advancements in prostate cancer and women's health. Christine Ro...
Phil Knight, co-founder of Nike, along with his wife Penny, has donated $2 billion to the Oregon Health & Science University (OHSU) to support the ...
Northwest Biotherapeutics, a biotechnology company specializing in personalized immune therapies for solid tumor cancers, has announced the passing...
A recent study published in Nature Communications has highlighted the impact of climate change on sleep patterns, focusing on data from mainland Ch...